Cadrenal director resigns; 2025 annual meeting set for Sept 24, proposal deadline July 28

Cadrenal Therapeutics, Inc.

Director Robert Lisicki resigned from board effective July 15, 2025, with no disagreement with the company.
2025 annual meeting scheduled for September 24, 2025; record date for voting is July 28, 2025.
Shareholder proposals for proxy inclusion must be received by July 28, 2025; director nominations also due July 28.
Universal proxy rule: shareholders soliciting proxies for director nominees must provide notice by July 28, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.